{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260824428528/en/Savara-Announces-Encore-Presentations-of-Results-from-the-Phase-3-Clinical-Trial-of-Molgramostim-Inhalation-Solution-Molgramostim-in-Autoimmune-Pulmonary-Alveolar-Proteinosis-APAP-at-the-European-Respiratory-Society-ERS-Congress-2026", "message": "News view counter 899580 successfully enlarged"}